Pluristem Therapeutics Inc. (PSTI) Shares Trade at New 52-Week Low
Pluristem Therapeutics Inc. (NASDAQ: PSTI; DAX: PJT) is a bio-therapeutics company working to commercialize non-personalized cell therapy products for the treatment of a variety of severe degenerative, autoimmune disorders for situations where current therapies are impractical. The company was founded in 2001 as A.I. Software, Inc. and changed its name to Pluristem Therapeutics, Inc. in November 2007. The company is based in Haifa, Israel. Pluristem’s pipeline of products is derived from mesenchymal stromal cells (MSCs) that are obtained from the human placenta, an organ that has traditionally been considered medical waste after childbirth. Because of this, it is a non-embryonic,…